Cargando…
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
Adults with obesity may develop asthma that is ineffectively controlled by inhaled corticosteroids and long-acting beta-adrenoceptor agonists. Mechanistic and translational studies suggest that metabolic dysregulation that occurs with obesity, particularly hyperglycemia and insulin resistance, contr...
Autores principales: | Ge, Derek, Foer, Dinah, Cahill, Katherine N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931991/ https://www.ncbi.nlm.nih.gov/pubmed/36575356 http://dx.doi.org/10.1007/s41030-022-00211-x |
Ejemplares similares
-
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
por: Foer, Dinah, et al.
Publicado: (2021) -
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study
por: Baek, Seung Han, et al.
Publicado: (2021) -
Hypoglycemic agents and potential anti-inflammatory activity
por: Kothari, Vishal, et al.
Publicado: (2016) -
Improving Mobile Health for Asthma in a Pandemic: Patient Use of an Integrated COVID-19 Screener
por: Foer, Dinah, et al.
Publicado: (2022) -
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
por: Wang, Liqin, et al.
Publicado: (2020)